Skip to main content

FDA Approvals

FDA Approvals
Oncology Pipeline Full, and Not Just with Immunotherapies
Caroline Helwick, Wayne Kuznar
Read More
FDA Approvals
FDA Update
Read More
FDA Approvals
CAR-T Cells: The Transplants of the Future
Chase Doyle
Read More
FDA Approvals
Encouraging Results for Pembrolizumab in Head and Neck Cancer
Phoebe Starr
Read More
FDA Approvals
Elotuzumab, First-in-Class Monoclonal Antibody Immuno­­therapy, Improves Outcomes in Patients with Multiple Myeloma
Phoebe Starr
Read More
FDA Approvals
Lenvatinib Extends Survival in Metastatic Renal-Cell Carcinoma
Wayne Kuznar
Read More
FDA Approvals
Nivolumab Makes Headwinds into Liver Cancer
Wayne Kuznar
Read More
FDA Approvals
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
Read More
FDA Approvals
Lemtrada (Alemtuzumab) a New Treatment Option Approved by the FDA for the Treatment of Relapsing Forms of Multiple Sclerosis
Loretta Fala
Read More
FDA Approvals
Farydak (Panobinostat): First HDAC Inhibitor Approved for the Treatment of Patients with Relapsed Multiple Myeloma
Lisa A. Raedler, PhD, RPh
Read More
Page 40 of 53
Results 391 - 400 of 522